Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Meant u may be looking at the otc sp
Portage still suspended on cse so think you may be looking at the cse sp. Best guess is around 28th of this month. https://thecse.com/en/listings/life-sciences/portage-biotech-inc
At last some light at the end of the tunnel ... Portage Biotech relisted on the Canadian exchange and showing around US$ 0.14, so up around 40% on the suspension price (US$0.10) and have heard from Barclays Smart Investor that my certificates are being prepared for sale (cannot have them in my ISA) once the Canadian regulators have ratified them. Expecting about £30k from the sale and still holding the SALV shares in UK in my investment account after they were removed from my ISA when delisted.
Hoping Mr Mellon will come up trumps with a relisting for SALV on the announcement of the exciting new developments he spoke of earlier this year.
https://privatebank.barclays.com/news-and-insights/2019/november/the-race-for-a-breakthrough-in-longevity-biotech/?cid=ad03mm01soc_sc02ca07cr01co71te01
Could what the cash shell will be aimed at?
Thought Juvanescence was part of our portfolio with Portage Biotech.
Sorry 10th Jan; Today! We are now de-listed.
Waiting for an announcement imminent Re; a reverse takeover (if it happens)
10th of? Feb?
Ok so cancellation of SALV on the 10th and hopefully an announcement of a reverse takeover and a new listing.
Lets hope it's a good one!
Pesto; Just had a quick scan though Agronomics, interesting; I guess it will be about economies of scale. It would need to be cheaper than traditional meat farmed production to make any real impact, at least in the short to medium term.
My feeling is that Vegan alternatives will have a greater impact, again in the short to medium term and possibly be the main market leader. Early days but one to watch!
I am now wondering if Jim Mellon will do something slimier with SALV .......We will soon find out!
Just a final thought are any of you guys invested in Agronomics? I have been holding for about 8 weeks..
Kentan, could not agree more, it has been painful and somewhat of a car crash. I have stock of portage showing in my II account but as you outline below cant trade or have a value. Barclays corporate complaints team are still battling on my behalf to have share certificates issued for the stock i had held within Smartinvestor.
Mellon and his team are very smart guys, however i do feel that on this occasion they would have been better keeping the Status Quo 18months ago and kept the Intensity investment within SALV. At the time Mellon stated that the demerger shares was the only way to release shareholder value... Well 18 months on and i dont see it that way at all... All good things come to those that wait??? jesterman im going to bookmark the page and keep us long suffering holders in comms and updates, anyone else joining us??
Thanks for that Kentan; Jim made some very interesting comments regarding Vegan foods and the advanced replication of animal proteins for meat and milk, which in effect make the rearing and slaughtering of animals obsolete!; quite remarkable! As for Vegan foods...well just look at Gregs the bakers big increase in profits just from their vegan sausage rolls! As far as I am concerned i'm not to bothered about loosing our listing. I think all will come good. Jim Mellon seems to be a very respected man in the city.
As far as this board is concerned it would seem that unless you keep a bookmark for this page, it cant be found. Most of the info and chat is now on the Portage Yahoo/usa. So if we do get a new listing from salv, I guess someone will have to start a new 'chat'
Good luck to us all ( is anyone els here??)
31/12/2019:
There is some good news of Portage Biotech, hoping to have its Cease Trading Order (CTO) revoked after filing up-to-date accounts and securing an extension to the strike-off procedure.
https://www.prnewswire.com/news-releases/portage-announces-filing-of-financial-statements-and-accompanying-mda-and-provides-company-operations-updates-300980014.html
Let us hope us poor souls still awaiting financial reward for the takeover of SalvRx Ltd 18 months ago can see some light at the end of the tunnel and finally get our hands on the 18 Portage shares for 1 SALV we were promised.
Meanwhile, the delisting of SALV from AIM on January 2020 now cannot be stopped, however it is encouraging to know that Jim Mellon & Co. are working diligently on the proposed t/o to diversify the company into new and better things.
After listening to his Climate Change & Laboratory Manufactured Meat Products thesis (to lower damaging animal methane gasses into the atmosphere) it seems this will be the road we will take ... from the committed vegan himself ...
Early days, but is spot on the new enterprises that venture capitalists are looking to invest in.
https://soundcloud.com/themoneyweekpodcast/issue-979-jim-mellon-at-the-moneyweek-wealth-summit Interesting talk by Jim Mellon
Because they will miss the deadline to complete a RTO of their intended target, the AIM registration will cease.
Unless the RTO is into a listed company into which they intend to reverse there will be no representation on AIM or other trading platforms, so Salvarx will become a private limited company with value, but not tradeable except by matched trades.
With no payment received from the Portage buyout and with their suspension preventing the issue of certificates, it has become a complete shambles, to say the least.
When there is any chance of monetary value to be achieved is anyone's guess, it just continues to show a black hole in my portfolio where there shouldn't be one.
Would appreciate some feedback from Jim Mellon who orchestrated this debacle.
Cancellation of trading on AIM / Potential acquisition
SalvaRx provides the following information regarding the admission of the Company's ordinary shares ("Ordinary Shares") to trading on AIM.
As previously announced, following the suspension of the Company's Ordinary Shares from trading on AIM on 9 July 2019 ("Suspension"), if neither a reverse takeover nor re-admission to trading on AIM as an investing company under the AIM Rules are completed within six months of the date of Suspension, then the Ordinary Shares will be cancelled from trading on AIM pursuant to AIM Rule 41.
As noted in the Company's interim results for the six months ended 30 June 2019, the Company has been evaluating a number of potential acquisition opportunities. The Company is now pleased to announce that it is in advanced discussions with an acquisition target which is a leader in the field of oral immune therapies. Should this proposed acquisition proceed, the Board of SalvaRx anticipates making a further announcement early in the new year, setting out full details of the transaction.
Despite efforts to conclude a reverse takeover before the cancellation date, it will not be possible to conclude the proposed transaction before 10 January 2020. On this basis, the cancellation of the admission to trading of the Ordinary Shares on AIM is expected to take effect from 7.00 a.m. on 10 January 2020.
What the implication will be when canceled I have no idea. Another listing?
https://www.morningstar.co.uk/uk/news/AN_1569504819959221600/salvarx-turns-to-interim-profit-evaluating-takeover-opportunities.aspx
Reported 26/09/2019:
Salvarx plc results posted for 6 months until 30th June 2019 show an upbeat report with profitable trading income of £11.4m on investments and cash reserves from proceeds of the sale of 94% Salvrx Ltd (net £53.1 million) to Portage Biotech.
This helped the firm jump to a pretax profit of £61.3 million from a £190,000 loss a year ago.
Whereas on 28th June 2019 it had reported losses widening for the full year (2018) from £2.2m to £3.4m and this took into account the sale to Portage.
https://www.morningstar.co.uk/uk/news/AN_1561722448946219200/salvarx-loss-widens-mulling-options-ahead-of-cash-shell-aim-deadline.aspx
Something is not right here?
I am someone who is still waiting to benefit from the demerger sale because Barclays (despite numerous requests) I cannot obtain Portage share certificates to trade (not allowable in my ISA), again complicated by both Portage Biotech & Salvarx plc currently suspended on their markets, whilst they are able to trade and prosper at no benefit to me although I am a shareholder in both.
Am I to be in limbo until both decide to re-list or is my investment lost forever in the mire of uncertainty whilst the directors benefit at my expense?
Not sure if any of you guys are still viewing the posts here. Either way update below i received yesterday..
Dear
I wanted to write to you, further to my previous email, to provide you with another update on the SalvaRX Group Plc Corporate Action.
Regrettably, since my last email a Cease Trading Order (CTO) has been implemented by the company which has affected the registrars response regarding the re-registration of your Portage Biotech holding.
To keep you updated, we have been advised the stock is under a "Cease Trade Order" which means the asset cannot be traded on any exchange/market. On this basis, the registrar has rejected our request to re-register these holdings based on the CTO being active. I appreciate this is not the answer you were hoping for.
To explain, we challenged this with the Chief Financial Officer of Portage Biotech and managed to achieve sign off for the registrar to complete our re-registration request. On 23 October 2019, the registrar was checking with their internal compliance department and the request was not yet completed. Be assured, we've chased the registrar for updates and completing your request remains a priority for us.
The registrars have since advised they require a legal affidavit in order to progress with our request to re-register your Portage Biotech holding. We have therefore referred to our Legal Team to provide this on our behalf. Unfortunately, due to this new information provided by the registrar, we are unable to confirm when you shall receive your certificate.
That being said, I will continue to provide you updates, once available, until you are in receipt of your Portage Biotech holding.
Kind regards
TORONTO, Aug. 26, 2019 /PRNewswire/ - Portage Biotech Inc. (PBT.U, OTC Markets: PTGEF) ("Portage" or the "Company") is providing an update on the status of the filing of its audited annual financial statements for the year ended March 31, 2019, accompanying management discussion and analysis together with the related certifications (collectively, the "Annual Filings"). The Annual Filings have been completed but are currently being reviewed for quality assurance by the Company's auditors. The Company anticipates that final approval and posting of the Annual Filings on www.sedar.com will be completed shortly.
As a consequence of the delay in the preparation of the Annual Filings, the Company also announces that the filing of its financial statements for the three-month period ended June 30, 2019, accompanying management discussion and analysis together with the related certifications (the "Interim Filings") will also be delayed and not released as required on August 29, 2019. The Company expects the Interim Filings to be filed shortly after the Annual Filings are filed.
On August 2, 2019, the Ontario Securities Commission (the "OSC") issued a Failure-to-File Cease Trade Order against the Company on (the "FFCTO") as a result of the Company's failure to the Annual Filings by the prescribed filing deadline of July 29, 2019, as required by National Instrument 51-102, Continuous Disclosure Obligations, and NI 52-109, Certification of Disclosure in Issuers' Annual and Interim Filings, respectively. The FFCTO remains in place.
The Company reports that since its news release of July 31, 2019, there have been no material changes regarding the information contained in that news release. Further, there is no other material information concerning the affairs of the Company that has not been generally disclosed.
You're right Jesterman, the whole Portage debacle has been an administrative ****-up. The fact that seven months down the line we still can't trade our Portage shares is ridiculous. Some shareholders have a share certificate, some (like myself) have been told that a share certificate can't be issued and have nominee held shares which can't be traded. And there is no information as to when PTGEF will be tradable on a major exchange. Very frustrating the whole thing.
Just been on HL's site to see if Portage shows up for trading; As far as I can see it will only list Portage (PBTu) which is on the Canadian Exchange. Unable to find Portage (PTGEF) which is on the American OCT market. Since I like many others (I am with II) have been informed, the shares are as far as I can work out, American OCT (PTGEF) which II clients have been informed that they are unable to deal on this exchange and like others on II have been informed that a share certificate will be issued within a few weeks.
This whole issue regarding Portage has been an administrative ****up, to say the least.
Can anyone provide any clarification that these (American OTC shares) can be dealt?
I am at a loss. Think I will go lye down in a darkened room !
Further correspondence from Barclays received this morning. This has been ongoing for 6months now.
Your Complaint- Transfer
Thank you for your email on 11 July. You are absolutely correct, we did receive certificates in April from Portage Biotech, however we are proactively trying to establish a way we can register the certificate in your name and have experienced issues contacting the Canadian Registrar to offer some clarity on this.
We have since established that we may be able to apply for a Medallion guarantee stamp but are aware there is a US legend restriction on the stock which may prevent the re-registration and therefore, need clarity.
Please note, we have been chasing this consistently and unfortunately have struggled to get the answers we are needing within a timescale we would like. I will be contact you as soon as we reach a solution.
Thaks Dougie999 and Jarcon.
Im still waiting for my Portage share certificates to be issued by Barclays Smart Investor, I have to say the demerger has not been a adminstrative success by Portage and or the Brokers.
There is a rel lack of RNS on what the next play is by Portage and where they might list?
i have spoken to II and they have said that once the share certificates have been sent out you can wait until portage deal with a market they deal in and they will arrange free of charge or deposit them with a different broker. when will we see some action here??
Morning Pesto,
I'm in the same boat as you with II,
it's why I asked Mike who he sold his shares with earlier.
I believe HL can trade them, though not 100% on that - thinking of opening another ISA with them and transferring the shares tbh.
If anyone has better ideas out there I'd love to hear them.
Thanks,
Morning all, i have received a corporate action notification from ii stating that they cant hold Portage shares as they are not listed on an exchnage that ii support. This is frustating as i moved my holding from Barclays smart investor to ii so i could trade this stock. Anyone else had this notification and what platform can you trade the stock on?
Stock
PORTAGE BIOTECH IN NPV
Event Type
Confirmation
Description
Demerger update - Portage Trading Status
Further to our notification dated the 19th February 2019 regarding the demerger of Portage Biotech Inc. from Salvarx Group plc, please be aware that the resultant Portage Biotech Inc. stock is not listed on a stock exchange that we support.
As the shares are no longer trading on a supported stock exchange we are arranging to issue you with a share certificate in relation to your holding. Please note this process may take a few weeks, as the share certificates will need to be issued by the company?s registrar.